Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 4Unknown 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Small Cell Lung Carcinoma 27Lymphoma, Large B-Cell, Diffuse 10Lung Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Non-Hodgkin 6Lymphoma, B-Cell 6Hodgkin Disease 6Burkitt Lymphoma 6Neuroblastoma 5Medulloblastoma 5Neoplasms, Germ Cell and Embryonal 4Leukemia, Myeloid, Acute 4Small Cell Lung Cancer Extensive Stage 3Seminoma 3Retinoblastoma 3Recurrence 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma 3Carcinoma, Neuroendocrine 3Brain Neoplasms 3Wilms Tumor 2Urinary Bladder Neoplasms 2Teratoma 2Sarcoma, Ewing 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Neuroectodermal Tumors, Primitive 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2

Interventions

pembrolizumab 6cabozantinib 6Nivolumab 5Ipilimumab 5Axitinib 5Radiosurgery 3Blood Specimen Collection 3zimberelimab 2lenvatinib 2Ultrasonography 2Radiotherapy 2Biopsy 2tislelizumab 1polyethylene glycol 3350 1pazopanib 1palbociclib 1orellanine 1olaparib 1gallium Ga 68 dotatate 1fludarabine 1cyclopropapyrroloindole 1brodalumab 1belzutifan 1atezolizumab 1anlotinib 1adagrasib 1Watchful Waiting 1Vincristine 1Therapeutics 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Kidney Neoplasms × Etoposide × Clear all
NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting
28 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡